Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the long-term safety of oxycodone hydrochloride
(HCl) controlled-release (CR) tablets in opioid experienced pediatric patients aged 6 to 17
years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid
therapy who completed the 4 -week treatment period in OTR3001.